Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 2Phase 2 1

Status

Completed 4Unknown 2Terminated 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Classical hematology 1

Conditions

Venous Thromboembolism 1Thromboembolism 1Lung Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × Tinzaparin × Clear all
NCT05625932 2025-08-22

PROTINCOL

Galician Research Group on Digestive Tumors

Phase 3 Completed
232 enrolled
Gastrointestinal

Thromboembolism, Colorectal Neoplasms

NCT01130025 2025-02-24

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

LEO Pharma

Phase 3 Completed
900 enrolled
Classical hematology

Venous Thromboembolism

NCT01455831 2021-05-17

PERIOP-01

Ottawa Hospital Research Institute

Phase 3 Completed
616 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00475098 2016-09-02

TILT

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
553 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡